(Q34801866)

4 August 2017

1 reference

title

STI and beyond: the prospects of boosting anti-HIV immune responses (English)

1 reference

4 August 2017

4

Bruce D Walker

1 reference

4 August 2017

1

Todd M Allen

1 reference

4 August 2017

2

Anthony D Kelleher

1 reference

4 August 2017

3

John Zaunders

1 reference

PubMed ID

12200068

4 August 2017

language of work or name

1 reference

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

23

1 reference

4 August 2017

9

1 reference

4 August 2017

456-460

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

A controlled trial of zidovudine in primary human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Early postinfection antiviral treatment reduces viral load and prevents CD4+ cell decline in HIV type 2-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Treatment interruption after one year of triple nucleoside analogue therapy for primary HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: effects on virologic, immunologic, and toxicity parameters

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Short Communication: Downregulation of Major Histocompatibility Class I on Human Dendritic Cells by HIV Nef Impairs Antigen Presentation to HIV-Specific CD8+ T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HIV-1 expression in chimpanzees can be activated by CD8+ cell depletion or CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Relative dominance of epitope-specific cytotoxic T-lymphocyte responses in human immunodeficiency virus type 1-infected persons with shared HLA alleles

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Quantifying the uncertainty in forecasts of anthropogenic climate change

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Latent infection of cells in HIV disease: abstract and commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimers

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

HLA-B*5703 independently associated with slower HIV-1 disease progression in Rwandan women.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2802%2902297-4

7 January 2021

10.1016/S1471-4906(02)02297-4

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12200068